Cryo-Cell International I...

NASDAQ: CCEL · Real-Time Price · USD
4.59
-0.09 (-1.92%)
At close: Aug 21, 2025, 3:57 PM
4.64
1.12%
Pre-market: Aug 22, 2025, 06:00 AM EDT

Cryo-Cell International Income Statement

Financials in USD. Fiscal year is December - November.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending May 31, 2025 Feb 28, 2025 Nov 30, 2024 Aug 31, 2024 May 31, 2024 Feb 29, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021
Revenue
31.99M 32.1M 31.99M 31.84M 31.64M 31.37M 31.34M 31.23M 31.04M 30.9M 30.34M 29.89M 29.71M 29.28M 28.88M 29.11M 29.72M 30.39M
Cost of Revenue
7.6M 7.77M 7.95M 8.39M 8.42M 8.54M 8.44M 8.51M 8.7M 8.76M 8.79M 8.95M 9.06M 9.08M 8.99M 9.01M 8.91M 9.17M
Gross Profit
24.39M 24.33M 24.04M 23.45M 23.22M 22.84M 22.9M 22.73M 22.34M 22.15M 21.54M 20.94M 20.65M 20.2M 19.9M 20.1M 20.81M 21.22M
Operating Income
3.82M 3.72M 3.48M -12.57M -12.8M -13.17M -12.3M 4.45M 4.66M 4.83M 4.61M 3.21M 3.44M 4.24M 4M 7.01M 7.89M 7.65M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
1.65M 2.54M 2.8M -12.35M -12.66M -13.78M -13.36M 3.25M 2.82M 3.38M 3.32M 1.45M 2.07M 2.81M 2.61M 5.69M 5.36M 5.05M
Net Income
-171.3K 128.71K 402.1K -8.93M -9.3M -9.73M -9.52M 2.51M 2.29M 2.71M 2.77M 1.3M 1.69M 2.22M 2.08M 3.92M 3.85M 3.63M
Selling & General & Admin
19.06M 18.82M 18.52M 17.9M 17.56M 17.58M 17.12M 16.41M 16.21M 16.08M 15.58M 15.44M 15.33M 14.57M 14.63M 13.57M 13.45M 13.86M
Research & Development
728.42K 837.79K 1.24M 1.38M 1.53M 1.6M 1.17M 804.05K 540.19K 316.4K 384.79K 338.83K 268.56K 190.9K 49.87K 26.49K 17.73K 24.32K
Other Expenses
784.16K 594.2K 402.4K 207.47K 307.00 281.25K 397.33K 676.86K 958.66K 957.5K 1.12M 840.02K 558.14K 278.24K 99.00 99.00 91.00 171.00
Operating Expenses
20.57M 20.31M 20.26M 19.87M 19.75M 20.05M 19.25M 18.17M 17.71M 17.36M 17.08M 16.9M 16.7M 15.85M 15.51M 14.19M 13.83M 14.03M
Interest Expense
2.33M 2.1M 1.86M 1.12M 1.06M 1.2M 1.41M 1.98M 1.88M 1.68M 1.52M 1.37M 1.34M 1.4M 1.38M 1.43M 1.43M 1.46M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -380.2K -380.2K -380.2K
Cost & Expenses
28.17M 28.08M 28.21M 28.25M 28.16M 28.58M 27.69M 26.68M 26.41M 26.11M 25.88M 25.85M 25.76M 24.93M 24.5M 23.19M 22.74M 23.19M
Income Tax Expense
1.82M 2.41M 2.4M -3.42M -3.36M -4.05M -3.84M 744.9K 531.99K 671.61K 547.54K 156.37K 386.95K 592.46K 527.71K 1.76M 1.51M 1.42M
Shares Outstanding (Basic)
8.08M 8.08M 8.13M 8.06M 8.12M 8.25M 8.34M 8.29M 8.33M 8.44M 8.48M 8.39M 8.44M 8.53M 8.45M 8.45M 7.95M 7.57M
Shares Outstanding (Diluted)
8.13M 8.2M 8.21M 8.17M 8.23M 8.25M 8.34M 8.34M 8.33M 8.44M 8.48M 8.4M 8.55M 8.75M 8.69M 8.69M 8.27M 8.2M
EPS (Basic)
-0.03 0.01 0.05 -1.06 -1.11 -1.16 -1.14 0.30 0.28 0.32 0.32 0.15 0.19 0.27 0.26 0.50 0.50 0.48
EPS (Diluted)
-0.03 0.01 0.05 -1.06 -1.11 -1.16 -1.14 0.30 0.28 0.32 0.32 0.15 0.20 0.26 0.25 0.48 0.48 0.46
EBITDA
3.62M 3.99M 3.83M -11.09M -9.51M -10.26M -9.34M 6.36M 5.86M 6.23M 6.04M 4.59M 5.13M 5.88M 5.32M 8.2M 7.64M 7.12M
EBIT
3.97M 4.65M 4.67M -11.4M -11.77M -12.76M -12.13M 5.23M 4.7M 5.06M 4.84M 2.82M 3.41M 4.22M 3.99M 7.12M 6.8M 6.51M
Depreciation & Amortization
1.51M 1.2M 1.02M 1.09M 1.18M 1.42M 1.71M 1.75M 1.78M 1.79M 1.81M 1.76M 1.71M 1.66M 1.33M 1.08M 841.09K 612.84K